Biosensor-guided discovery of peptide inhibitors targeting the ribosomal protein uS5-PDCD2 chaperone interaction
Programmed cell death 2 (PDCD2) is an evolutionarily conserved protein essential for cell viability from yeast to humans. PDCD2 functions as a dedicated chaperone to the 40S ribosomal protein uS5, and loss of PDCD2 function impairs ribosome biogenesis. As cancer cells require a substantial supply of ribosomes to maintain elevated levels of protein synthesis, targeting the protein interaction interface between PDCD2 and uS5 is a promising modality to mitigate ribosome biogenesis. In this study, we used affinity purification assays and structural modeling to identify a stretch of 30 amino acids in the N-terminal region of uS5 that is necessary and sufficient for interaction with PDCD2. Our data also identified a conserved FxxGFG motif in uS5 that is important for association with PDCD2 via hydrophobic interactions. Notably, we developed a sensitive complementation-based biosensor that can monitor PDCD2-uS5 interaction in cell extracts and living human cells. Using this biosensor, we identified an 11-amino acid uS5-derived peptide that inhibits the PDCD2-uS5 interaction and impairs cancer cell viability. Such peptides provide a starting point in the development of peptidomimetic inhibitors capable of modulating ribosome biogenesis via disruption of ribosomal protein-dedicated chaperone complexes.
Authors
- Zabih Mir Hassani (ORCID: https://orcid.org/0000-0001-8138-6651)
- Taha Azad (ORCID: https://orcid.org/0000-0002-9498-0657)
- Anne-Marie Landry-Voyer
- Pierre‐Luc Boudreault (ORCID: https://orcid.org/0000-0002-2032-7970)
- Lauren Kwiatek
- François Bachand
- Shany Gaudet
- Frédérique Goulet
- Duc Tai Nguyen
Institutions
- Université de Sherbrooke (CA)
Publication Details
- Journal
- Journal of Biological Chemistry
- Published
- 2026-03-31
- DOI
- https://doi.org/10.1016/j.jbc.2026.111415
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Canadian Institutes of Health Research